Founder, FlowCo/RetInnovate | CEO, MediNect Bioservices

James is the founder of RetInnovate, an initiative sparked by his observations of promising therapies repeatedly failing at the clinical trial stage — often due to avoidable gaps in planning, under-preparedness, and a lack of translational alignment. Through conversations with clinicians and key stakeholders across the value chain, he recognised a recurring disconnect between early-stage innovation and the realities of clinical development. RetInnovate was created to bridge that gap — fostering smarter, earlier integration of commercial and clinical considerations.

With over a decade of experience in preclinical research, James specialises in animal model development and brings deep insight into the needs of pCROs and biotech innovators. As founder and CEO of MediNect Bioservices, he has assembled a mission-driven team dedicated to advancing research models, driving strategic growth, and delivering outstanding client service.

James is passionate about helping science move beyond the lab — empowering innovators to translate great ideas into real-world success through smarter planning, stronger models, and better cross-functional collaboration. purpose and precision.